[Moraxella (Acinetobacter) and meningeal syndrome. Isolation in Fort-Lamy (Chad) of 17 strains from the cerebrospinal fluid].
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001431:Bacteriological Techniques; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002596:Chad; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D003470:Culture Media; D004352:Drug Resistance, Microbial; D006801:Humans; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology*; D008585:Meningitis, Meningococcal; D009016:Moraxella / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity; D013129:Spinal Puncture; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003470:Culture Media; D002701:Chloramphenicol; D013421:Sulfamethoxypyridazine
"Moraxella" (Acinetobacter) et syndrome méningé. A propos de l'isolement à Fort-Lamy (Tchad) de 17 souches provenant de L.C.-R.